Search Results - Angelika Mehnert

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year

    Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year by Fleischhacker, W. Wolfgang, Rabinowitz, Jonathan, Kemmler, Georg, Eerdekens, Mariëlle, Mehnert, Angelika

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology

    Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common compa... by Van Sanden, Suzy, Pisini, Marta, Duchesne, Inge, Mehnert, Angelika, Belsey, Jonathan

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

    Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany by Laux, Gerd, Heeg, Bart, van Hout, Ben A, Mehnert, Angelika

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis

    Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis by De Graeve, Diana, Smet, Ann, Mehnert, Angelika, Caleo, Sue, Miadi-Fargier, Houda, Mosqueda, Guillermo Jasso, Lecompte, Damien, Peuskens, Joseph

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Objectivity in research in the pharmaceutical industry is possible

    Objectivity in research in the pharmaceutical industry is possible by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

    Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands by Caro, J. Jaime, Salas, Maribel, Ward, Alexandra, Getsios, Denis, Mehnert, Angelika

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for I year

    Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for I year by FLEISCHHACKER, W. Wolfgang, RABINOWITZ, Jonathan, KEMMLER, Georg, EERDEKENS, Mariëlle, MEHNERT, Angelika

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany: Costs and effects of the use of long-acting risperidone in the treatment of schizophrenia

    Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany: Costs and effects of the use of long-acting risperidone in... by LAUX, Gerd, HEEG, Bart M. S, VAN HOUT, Ben A, MEHNERT, Angelika

    Published in PharmacoEconomics
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Objectivity in research in the pharmaceutical industry is possible

    Objectivity in research in the pharmaceutical industry is possible by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Objektive Forschung der Pharmaindustrie ist möglich

    Objektive Forschung der Pharmaindustrie ist möglich by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  11. 11
    Patient Satisfaction with Their Medication Increases during 1 Year of Treatment with Long-Acting Risperidone Injection

    Patient Satisfaction with Their Medication Increases during 1 Year of Treatment with Long-Acting Risperidone Injection by Carmela C. Janagap, Angelika Mehnert, Harald J. Freyberger, Inge Y. Duchesne

    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Long-Acting, Injectable Risperidone: The First Long-Acting, Atypical Antipsychotic: Improves Quality of Life

    Long-Acting, Injectable Risperidone: The First Long-Acting, Atypical Antipsychotic: Improves Quality of Life by Nasrallah, Henry A., Inge Y. Duchesne, Angelika Mehnert, Carmela C. Janagap

    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia : a Belgian cost-effectiveness analysis: Costs and effects of the use of long-acting risperidone in the treatment of schizophrenia

    Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia : a Belgian cost-effectiveness analysis: Costs and effects of the use of long-acting ri... by DE GRAEVE, Diana, SMET, Ann, MEHNERT, Angelika, CALEO, Sue, MIADI-FARGIER, Houda, MOSQUEDA, Guillermo Jasso, LECOMPTE, Damien, PEUSKENS, Joseph

    Published in PharmacoEconomics
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: